Results for "consumer data right"
431-440 of 532 results for 'consumer data right'
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...
New ASIC guidance on how superannuation and managed funds can avoid 'greenwashing'
Greenwashing in the promotion of managed investment and superannuation funds is one of ASIC's current corporate governance priorities as it continues to 'monitor the market … looking for misleading claims about ESG and sustainability'. ...
ASIC ramps up greenwashing-related regulatory interventions, targeting managed funds and ASX listed entities
ASIC's latest report, ASIC's recent greenwashing interventions (the Report), outlines its recent surveillance activities and regulatory interventions to tackle misleading marketing and greenwashing. ...
World first: Australia says ‘yes’ to AI inventors
The decision in Thaler v Commissioner of Patents [2021] FCA 879 is the first judicial determination in the world in favour of AI systems being named as inventors of a patent. The availability of patent protection for AI-generated inventions is a vexed and controversial issue. ...
The pitfalls of pre-emptive rights
In this Insight, we consider an alternative approach that may better balance the rights of selling and non-selling investors where a pre-emptive right remains appropriate. ...
Hydrogen is here - are you ready?
Following the release of the National Hydrogen Strategy in 2019, Australia is seeing exciting developments in government funding, new project announcements and private sector interest in a hydrogen industry. Federal and state governments are partnering with the private sector to support hydrogen technologies, in the race to become a premier exporter of clean hydrogen to the decarbonised global economy. This Insight explores the opportunities for Australia to establish a leading hydrogen industry, including recent policy developments, the latest funding announcements and key legal issues to be aware of. ...
Patent term extensions under siege: a new era of challenges for pharmaceutical patentees
A recent Federal Court decision has struck down a patent term extension granted to Novartis for its blockbuster heart failure drug Entresto. The decision in Novartis AG v Pharmacor Pty Limited follows a recent trend of successful challenges by generic pharmaceutical companies. ...
Recent developments in foreign investment (FIRB) regulation
The Federal Government's recent changes to foreign investment policies released on 14 March 2025 introduce significant modifications. In this Insight, we: examine the Government's latest foreign inve ...
Dollars and sense: the evolution of executive remuneration practices
The need for robust executive remuneration frameworks is becoming increasingly important as companies tackle the challenges arising out of the COVID-19 pandemic, a heightened regulatory environment and the need to strike the right balance with executives to drive and reward conduct and performance t ...
FIRB fee changes aimed at increasing affordable housing supply
On 10 December 2023, the Federal Government announced changes to the Foreign Investment Review Board residential land fee rules, designed to 'improve housing affordability and supply'. ...